Detalhe da pesquisa
1.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
N Engl J Med
; 389(4): 335-347, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272512
2.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Lancet Oncol
; 25(5): e205-e216, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697166
3.
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper.
Br J Haematol
; 204(4): 1193-1206, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393718
4.
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.
Blood
; 140(16): 1816-1821, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853156
5.
Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study.
Hematol Oncol
; 42(2): e3258, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402467
6.
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network.
Lancet Oncol
; 24(6): e255-e269, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269857
7.
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.
Br J Haematol
; 201(4): 682-689, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822820
8.
"What I wanted to do was build myself back up and prepare": qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma.
BMC Cancer
; 23(1): 348, 2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069548
9.
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial.
Acta Oncol
; 62(7): 696-705, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794394
10.
High patient satisfaction and increased physical activity following a remote multidisciplinary team multiple myeloma clinic.
Support Care Cancer
; 31(2): 127, 2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680643
11.
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
Br J Haematol
; 198(2): 328-332, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509237
12.
Multiple myeloma.
Lancet
; 397(10272): 410-427, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516340
13.
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
Lancet
; 397(10292): 2361-2371, 2021 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097854
14.
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
; 136(26): 3033-3040, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367546
15.
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
Hematol Oncol
; 40(5): 1020-1029, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653225
16.
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes.
Ann Hematol
; 101(10): 2123-2137, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943588
17.
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis.
Eur J Haematol
; 109(5): 504-512, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871357
18.
Myeloma patients' experiences of a supervised physical activity programme: a qualitative study.
Support Care Cancer
; 30(7): 6273-6286, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467117
19.
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Support Care Cancer
; 30(9): 7469-7479, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657402
20.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 22(3): e105-e118, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662288